Expression analysis of BMP2 reveals that both primary and metastatic melanomas with poorer survival showed lower expression levels of BMP2, while higher expression was associated with improved survival favouring an anti‐tumoral effect in melanomas. The gene discussed is BMP2; the disease is melanoma.